SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-009363
Filing Date
2022-04-07
Accepted
2022-04-07 16:43:15
Documents
19
Period of Report
2022-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52415
2 ex1-1.htm EX-1.1 58525
3 ex5-1.htm EX-5.1 14760
4 ex10-1.htm EX-10.1 273551
5 ex99-1.htm EX-99.1 10480
6 ex99-1_001.jpg GRAPHIC 2805
7 ex5-1_001.jpg GRAPHIC 5204
8 ex5-1_003.jpg GRAPHIC 32290
  Complete submission text file 0001493152-22-009363.txt   711332

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE clsn-20220407.xsd EX-101.SCH 3030
10 XBRL LABEL FILE clsn-20220407_lab.xml EX-101.LAB 34476
11 XBRL PRESENTATION FILE clsn-20220407_pre.xml EX-101.PRE 22593
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3617
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 22814382
SIC: 2834 Pharmaceutical Preparations